Monthly Recap: China Pharmaceutical Regulatory Updates | July 2021

by Grace Wang Aug 24, 2021

Editor's Note: The monthly recap is a brief collection of recently-issued drug laws, regulations and policies in China, especially those issued by National Medical Products Administration (NMPA) and the Center for Drug Evaluation (CDE).

Grace Wang
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact